As MCOs contend with more federal and state-level regulations, below are a few adjustments leaders can make to ensure compliance while Medicaid enrollees increase.
As COVID-19 continues to disrupt the economy and keep many out of work, and Medicaid expansion continues across the country, states must prepare for new strains on the Medicaid system.
According to a recent report from the Urban Institute, states that are expanding Medicaid can expect more than half of the people who are newly unemployed to join plans. In non-expansion states, one-third of those who lost employer-sponsored health insurance are likely to become eligible for Medicaid. As enrollees increase, Managed Care Organizations (MCOs) will be put to the test, especially when it comes to ensuring submitted encounter data are compliant, timely and accurate.
The healthcare industry often discusses encounter management in terms of risk adjustment and Medicare Advantage, but the reality is MCOs are under more intense encounter scrutiny than ever before, from the Office of the Inspector General (OIG) and even more so from state-level regulators’ compliance standards.
The OIG announced a planned study by 2021 of three to five states to determine if states had the required elements and steps to ensure that managed care encounter data is accurate and complete. The risk of noncompliance can be costly to the state (which could lead to reductions in Medicaid funding) as well as the MCOs themselves in the form of state-levied financial penalties.
As MCOs contend with more federal and state-level regulations, below are a few adjustments leaders can make to ensure compliance:
In the midst of widespread unemployment and continuous expansion to state Medicaid systems, MCOs are falling under increased scrutiny by both state and federal offices. Keeping these three elements in mind can mean the difference between struggling to update sub-optimal systems and being subjected to non-compliance penalties, and enjoying business continuity and continuous compliance.
Aaron Fulner is senior director at Edifecs focused on insurers involved in commercial, managed Medicaid, Medicare Advantage, and dual eligible programs.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Mental Health Comorbidities Affect Uptravi Prescribing for PAH
October 23rd 2024New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi (selexipag) to pulmonary arterial hypertension (PAH) patients with mental health conditions when evidence suggests that it is best to take a proactive approach to treating PAH.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
High-Dose Eylea Shows Unique Properties in nAMD and DME | AAO 2024
October 22nd 2024A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks to as long as 20 weeks for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
Read More